These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17509058)

  • 41. Demographic and socioeconomic predictors of melanoma prognosis in the United States.
    Eide MJ; Weinstock MA; Clark MA
    J Health Care Poor Underserved; 2009 Feb; 20(1):227-45. PubMed ID: 19202259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma.
    Uliasz A; Lebwohl M
    Int J Dermatol; 2007 Jun; 46(6):575-7. PubMed ID: 17550554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seasonal pattern of the diagnosis of cutaneous melanoma: a hospital-based study in a Mediterranean country.
    Nikolaou V; Stratigos AJ; Antoniou C; Sypsa V; Stefanaki I; Papadopoulos O; Danopoulou I; Hampsas G; Plaka M; Polydorou D; Katsambas AD
    Int J Dermatol; 2007 Nov; 46(11):1136-40. PubMed ID: 17988331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Changes in incidence of malignant melanoma in the last 19 years in a tertiary hospital on the Mediterranean coast].
    Marcoval J; Moreno A; Torras A; Baumann E; Graells J; Gallego MI
    Actas Dermosifiliogr; 2008; 99(6):464-8. PubMed ID: 18558054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Malignant melanoma in Chile: an unusual distribution of primary sites in men from low socioeconomic strata.
    Zemelman V; Roa J; Tagle SR; Valenzuela CY
    Clin Exp Dermatol; 2006 May; 31(3):335-8. PubMed ID: 16681570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Slip! Slap! Slop! Cutaneous malignant melanoma incidence and social status in New Zealand, 1995-2000.
    Pearce J; Barnett R; Kingham S
    Health Place; 2006 Sep; 12(3):239-52. PubMed ID: 16546691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution of clinical-pathological types of cutaneous melanomas and mortality rate in the region of Passo Fundo, RS, Brazil.
    Borges SZ; Bakos L; Cartell A; Wagner M; Agostini A; Lersch E
    Int J Dermatol; 2007 Jul; 46(7):679-86. PubMed ID: 17614794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trends during a half century in relative squamous cell carcinoma distribution by body site in the Swedish population: support for accumulated sun exposure as the main risk factor.
    Dal H; Boldemann C; Lindelöf B
    J Dermatol; 2008 Feb; 35(2):55-62. PubMed ID: 18271799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multicentric prospective study on the prevalence of sublevel IIb metastases in head and neck cancer.
    Villaret AB; Piazza C; Peretti G; Calabrese L; Ansarin M; Chiesa F; Pellini R; Spriano G; Nicolai P
    Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):897-903. PubMed ID: 17875856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prenatal risk factors for cutaneous malignant melanoma: follow-up of 2,594,783 Danes born from 1950 to 2002.
    Olesen AV; Parner ET; Mortensen PB; Sørensen HT; Olsen J
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):155-61. PubMed ID: 19124493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thick melanoma: the problem continues.
    Tejera-Vaquerizo A; Mendiola-Fernández M; Fernández-Orland A; Herrera-Ceballos E
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):575-9. PubMed ID: 18081751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiological data on melanoma from the referral centre in croatia (2002-2007).
    Buljan M; Rajacić N; Vurnek Zivković M; Blajić I; Kusić Z; Situm M
    Coll Antropol; 2008 Oct; 32 Suppl 2():47-51. PubMed ID: 19138006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Left-sided excess of invasive cutaneous melanoma in six countries.
    Brewster DH; Horner MJ; Rowan S; Jelfs P; de Vries E; Pukkala E
    Eur J Cancer; 2007 Dec; 43(18):2634-7. PubMed ID: 17988856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison between familial and sporadic cutaneous melanoma in Valencia, Spain.
    Nagore E; Botella-Estrada R; Garcia-Casado Z; Requena C; Serra-Guillen C; Llombart B; Sanmartin O; Guillen C
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):931-6. PubMed ID: 18355200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Occupational physical activity and risk of malignant melanoma: the Western Canada Melanoma Study.
    Lee TK; MacArthur AC; Gallagher RP; Elwood MJ
    Melanoma Res; 2009 Aug; 19(4):260-6. PubMed ID: 19531966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Melanoma reporting in Missouri.
    Weiner R; Anderson C; Edison K; Greer E
    Mo Med; 2004; 101(6):598-601; quiz 601-2. PubMed ID: 15679002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin.
    Coté TR; Sobin LH
    Melanoma Res; 2009 Feb; 19(1):58-60. PubMed ID: 19430407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time trends in the incidence of conjunctival melanoma in Sweden.
    Triay E; Bergman L; Nilsson B; All-Ericsson C; Seregard S
    Br J Ophthalmol; 2009 Nov; 93(11):1524-8. PubMed ID: 19628487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Follow-up schedules after treatment for malignant melanoma.
    Francken AB; Accortt NA; Shaw HM; Colman MH; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
    Br J Surg; 2008 Nov; 95(11):1401-7. PubMed ID: 18844268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
    Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
    Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.